Main
>
ONCOLOGY (**)
>
Multiple Myeloma***
>
Treatment
>
Co: IN. R. DoxoRubicin Liposome+
>
(*) USA Approval Date: 2017. 05.17
(*) USA Approval Date: 2017. 05.17's products
This section has no products